BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fung J. Era of direct acting antivirals in chronic hepatitis C: Who will benefit? World J Hepatol 2015; 7(24): 2543-2550 [PMID: 26523206 DOI: 10.4254/wjh.v7.i24.2543]
URL: https://www.wjgnet.com/1948-5182/full/v7/i24/2543.htm
Number Citing Articles
1
David Whiteley, Anne Whittaker, Lawrie Elliott, Sarah Cunningham-Burley. The lived experience of interferon-free treatments for hepatitis C: A thematic analysisInternational Journal of Drug Policy 2016; 38: 21 doi: 10.1016/j.drugpo.2016.10.013
2
Kazem Baesi, Ali Akbar Velayati, Masoumeh Farrokh Ashtiani, Kamal Fakhredini, Mohammad Banifazl, Mona Sadat Larijani, Parya Basimi, Amitis Ramezani. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected PatientsCurrent HIV Research 2021; 19(5): 391 doi: 10.2174/1566523221666210707142838
3
Sergio Estefan, Carlos Eduardo Brandão-Melo, Cintia Marques dos Santos Silva, Danilo Cosme Klein Gomes, Paula Cardoso, Marcia Helena S. Costa. Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral AgentsFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.631600
4
Anna Krzeczkowska, Paul Flowers, Zoe Chouliara, Peter Hayes, Adele Dickson. ‘It’s been a long haul, a big haul, but we’ve made it’: hepatitis C virus treatment in post-transplant patients with virus recurrence: An interpretative phenomenological analysisHealth Psychology Open 2018; 5(2): 205510291879267 doi: 10.1177/2055102918792673
5
Angeline Oi‐Shan Lo, Henry Lik‐Yuen Chan, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong. Cost‐effectiveness of the highly effective direct‐acting antivirals in the treatment of chronic hepatitis C in Hong KongJournal of Gastroenterology and Hepatology 2017; 32(5): 1071 doi: 10.1111/jgh.13638
6
Jessica L. Petrick, Andrea A. Florio, Rohit Loomba, Katherine A. McGlynn. Have incidence rates of liver cancer peaked in the United States?Cancer 2020; 126(13): 3151 doi: 10.1002/cncr.32794
7
Mohammad I. Saleh, Suhad Bani Melhim. A time-to-event analysis describing virologic response in patients with chronic hepatitis C infectionJournal of Chemotherapy 2019; 31(5): 274 doi: 10.1080/1120009X.2019.1609739
8
David Etoori, Monica Desai, Sema Mandal, William Rosenberg, Caroline A Sabin. A scoping review of media campaign strategies used to reach populations living with or at high risk for Hepatitis C in high income countries to inform future national campaigns in the United KingdomBMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08603-3